Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

TransMedics (TMDX) Return on Sales (2018 - 2025)

TransMedics has reported Return on Sales over the past 8 years, most recently at 0.12% for Q4 2025.

  • Quarterly results put Return on Sales at 0.12% for Q4 2025, up 6.0% from a year ago — trailing twelve months through Dec 2025 was 0.17% (up 9.0% YoY), and the annual figure for FY2025 was 0.0%, down 8.0%.
  • Return on Sales for Q4 2025 was 0.12% at TransMedics, down from 0.17% in the prior quarter.
  • Over the last five years, Return on Sales for TMDX hit a ceiling of 3.7% in Q4 2021 and a floor of 2.39% in Q3 2021.
  • Median Return on Sales over the past 5 years was 0.01% (2023), compared with a mean of 0.11%.
  • Biggest five-year swings in Return on Sales: skyrocketed 454bps in 2021 and later plummeted -393bps in 2022.
  • TransMedics' Return on Sales stood at 3.7% in 2021, then crashed by -106bps to 0.22% in 2022, then skyrocketed by 113bps to 0.03% in 2023, then soared by 96bps to 0.06% in 2024, then surged by 102bps to 0.12% in 2025.
  • The last three reported values for Return on Sales were 0.12% (Q4 2025), 0.17% (Q3 2025), and 0.22% (Q2 2025) per Business Quant data.